Takeda Pharmaceutical Company Limited Proceeds From Borrowings Classified As Financing Activities
Takeda Pharmaceutical Company Limited (TKPHF) reported Proceeds From Borrowings Classified As Financing Activities of JPY 1.02 trillion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2025-06-25
| Period end | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|
| 2025-03-31 | 1.02T JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 100.00B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 75.00B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 249.33B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.18T JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 496.19B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 2.80T JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 393.45B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 260.23B JPY 20-F · filed 2019-06-27 |